Laboratory-confirmed shigellosis in the United States, 1989-2002: Epidemiologic trends and patterns

被引:97
作者
Gupta, A
Polyak, CS
Bishop, RD
Sobel, J
Mintz, ED
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Foodborne & Diarrheal Dis Branch, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Appl Publ Hlth Training, Epidemiol Program Off,Epidem Intelligence Serv, Atlanta, GA 30333 USA
[3] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Bacterial & Mycot Dis, Biostat & Informat Management Branch, Atlanta, GA 30333 USA
关键词
D O I
10.1086/386326
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During 1989-2002, a total of 208,368 laboratory-confirmed Shigella infections were reported to the Centers for Disease Control and Prevention. Shigella sonnei accounted for 71.7%, Shigella flexneri accounted for 18.4%, Shigella boydii accounted for 1.6%, and Shigella dysenteriae accounted for 0.7% of infections; for 7.6%, no serogroup was reported. National incidence rates ranged from 7.6 cases per 100,000 persons in 1993 to 3.7 cases per 100,000 persons in 1999. Incidence rates for S. boydii, S. dysenteriae, and S. flexneri decreased over the 14-year period by 81%, 83%, and 64%, respectively; S. sonnei rates only decreased by 8%. The highest rates were reported from western states (10.0 cases per 100,000 persons) and among children 1-4 years of age (20.6 cases per 100,000 persons). The female-male S. sonnei incidence rate ratio among 20-39-year-old adults decreased from 2.3 during 1989-1999 to 1.4 during 2000-2002. Approximately 1% of isolates were from extraenteric sources; 0.25% were from blood. S. sonnei remains an important cause of diarrhea in the United States. Prevention efforts that target high-risk groups are needed.
引用
收藏
页码:1372 / 1377
页数:6
相关论文
共 38 条
[1]  
Acheson D. W., 2002, INFECT GASTROINTESTI, P763
[2]   Urinary tract infection caused by Shigella sonnei [J].
Anatoliotaki, M ;
Galanakis, E ;
Tsekoura, T ;
Schinaki, A ;
Stefanaki, S ;
Tsilimigaki, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (6-7) :431-433
[3]  
BLASER MJ, 1983, J INFECT DIS, V147, P771, DOI 10.1093/infdis/147.4.771
[4]  
Bopp CA, 2003, MANUAL CLIN MICROBIO, P654
[5]  
CASPER LM, 1998, 21 US BUR CENS POP D
[6]  
*CDCP, ANN FOODNET REP 2000
[7]  
*CDCP, 2001, MMWR-MORBID MORTAL W, V50, P922
[8]   Infection control challenges in child-care centers [J].
Churchill, RB .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (02) :347-+
[9]   Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults [J].
Cohen, D ;
Ashkenazi, S ;
Green, MS ;
Gdalevich, M ;
Robin, G ;
Slepon, R ;
Yavzori, M ;
Orr, N ;
Block, C ;
Ashkenazi, I ;
Shemer, J ;
Taylor, DN ;
Hale, TL ;
Sadoff, JC ;
Pavliakova, D ;
Schneerson, R ;
Robbins, JB .
LANCET, 1997, 349 (9046) :155-159
[10]  
Cordaro NM, 2001, J BIOMED MATER RES, V56, P109, DOI 10.1002/1097-4636(200107)56:1<109::AID-JBM1075>3.0.CO